IL‐17 is associated with disease severity and targetable inflammatory processes in heart failure

MLA

Lukas Baumhove, et al. “IL‐17 Is Associated with Disease Severity and Targetable Inflammatory Processes in Heart Failure.” ESC Heart Failure, vol. 11, no. 6, Dec. 2024, pp. 3530–38. EBSCOhost, https://doi.org/10.1002/ehf2.14968.

APA

Lukas Baumhove, Bart J. vanEssen, Martin M. Dokter, Sietske N. Zijlstra, Frederik E. Deiman, Jon D. Laman, Chim C. Lang, Gwenny M.P.J. Verstappen, Dirk J. vanVeldhuisen, Peter van derMeer, Nils Bomer, & Adriaan A. Voors. (2024). IL‐17 is associated with disease severity and targetable inflammatory processes in heart failure. ESC Heart Failure, 11(6), 3530–3538. https://doi.org/10.1002/ehf2.14968

Chicago

Lukas Baumhove, Bart J. vanEssen, Martin M. Dokter, Sietske N. Zijlstra, Frederik E. Deiman, Jon D. Laman, Chim C. Lang, et al. 2024. “IL‐17 Is Associated with Disease Severity and Targetable Inflammatory Processes in Heart Failure.” ESC Heart Failure 11 (6): 3530–38. doi:10.1002/ehf2.14968.